Injective Weekly Analysis
Injective (INJ) has been the biggest gainer of the week with a robust increase of 20.43%. After reaching an all-time high (ATH) of $53.01, INJ experienced a significant sell-off, filling the Fair Value Gap (FVG) on the daily timeframe and touching a low of $18.70 before quickly bouncing back. Currently, INJ is trading within a range of $21.54 to $29, facing multiple rejections around the $29 mark. Despite these rejections, INJ is showing a slight bullish trend, forming higher highs and lower lows. If INJ manages to break out of this range, it could potentially surge to the next resistance level at $34.
On both daily and weekly timeframes, moving averages strongly indicate a bullish signal, while oscillators remain neutral. Fundamentally, INJ is a strong asset to include in a portfolio. It is advisable to consider buying INJ during price dips to take advantage of potential discounts.
On both daily and weekly timeframes, moving averages strongly indicate a bullish signal, while oscillators remain neutral. Fundamentally, INJ is a strong asset to include in a portfolio. It is advisable to consider buying INJ during price dips to take advantage of potential discounts.
交易進行
INJ has broke the channel and has touched $32.99註釋
Update: Injective announces integration of Paxos and PayPal’s joint stablecoin PPYUSD, becoming one of the first L1 platforms to support the token.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。